There are no studies investigating Cannabidiol (CBD) in an acute pain model in human beings. This is however of great clinical value because:~Patients are often treated insufficiently with the commonly used analgesics in acute pain therapy or the available selection of analgesics is limited by their contraindications and side-effects.~CBD could be an option to optimize pain therapy if the pain relief is not satisfactory.~CBD in contrast to ∆9-tetrahydrocannabinol (THC) has only few side effects and due to a possible dose reduction of other analgesics patients might benefit from a better side-effect profile.~This study is to investigate the effect of CBD on acute pain in healthy volunteers in a well-established acute pain model.
This study is to investigate the effect of CBD on acute pain in healthy volunteers in a well-established acute pain model.